Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts
[ An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced 61 per cent in 2020, the biggest gain since 2003 as the pandemic fuelled online delivery channels. WuXi Biologics, the biggest constituent with 20.5 per cent weight, surged 213 per cent, making it the … Read more
